Clinical trial
A Metabolomics-based Study to Explore the Mechanism of Remission of Metabolic Syndrome Radical Resection of Colorectal Cancer
NCT06710314 is registered in ClinicalTrials.gov with Dong Peng as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Metabolomics-based Study to Explore the Mechanism of Remission of Metabolic Syndrome Radical Resection of Colorectal Cancer
- Lead sponsor
- Dong Peng
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- July 1, 2024
- Completion date
- July 1, 2026
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
metabolomics